4.7 Article

Alcohol consumption and diabetes risk in the Diabetes Prevention Program

期刊

AMERICAN JOURNAL OF CLINICAL NUTRITION
卷 90, 期 3, 页码 595-601

出版社

OXFORD UNIV PRESS
DOI: 10.3945/ajcn.2008.27382

关键词

-

资金

  1. Diabetes Prevention Program, National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases
  2. National Institute of Child Health and Human Development
  3. National Institute on Aging
  4. The Office of Research on Minority Health and Health Disparities
  5. Office of Women's Health
  6. Indian Health Service
  7. Centers for Disease Control and Prevention
  8. General Clinical Research
  9. National Center for Research Resources
  10. American Diabetes Association
  11. Bristol-Myers Squibb
  12. Lipha Pharmaceuticals, Inc
  13. Parke-Davis. LifeScan Inc
  14. Health O Meter, Hoechst Marion Roussel, Inc
  15. Merck-Medco Managed Care Inc
  16. Merck and Co
  17. Nike Sports Marketing
  18. Slim Fast Foods Co
  19. Quaker Oats Co donated the materials, equipment

向作者/读者索取更多资源

Background: Moderate alcohol consumption is associated with a decreased risk of type 2 diabetes in the general population, but little is known about the effects in individuals at high risk of diabetes. Objectives: The objectives were to determine associations between alcohol consumption and diabetes risk factors and whether alcohol consumption was a predictor of incident diabetes in individuals enrolled in the Diabetes Prevention Program (DPP). Design: DPP participants (n = 3175) had impaired glucose tolerance (2-h glucose: 7.8-11.1 mmol/L), elevated fasting glucose (5.3-7.0 mmol/L), and a body mass index (in kg/m(2)) >= 24. Participants were randomly assigned to placebo, metformin, or lifestyle modification and were followed for a mean of 3.2 y. Alcohol intake was assessed at baseline and year 1 by using a semiquantitative food-frequency questionnaire. Diabetes was diagnosed by annual oral-glucose-tolerance testing and semiannual fasting plasma glucose measurement. Results: Participants who reported higher alcohol consumption tended to be male, older, white, and less obese and to have a higher calorie intake and a higher HDL-cholesterol concentration. Higher alcohol consumption was associated with lower insulin secretion at any level of insulin sensitivity. We found lower incidence rates of diabetes with higher alcohol consumption in the metformin (P < 0.01 for trend) and lifestyle modification (P = 0.02 for trend) groups, which remained significant after adjustment for multiple baseline covariates. No similar association was observed in the placebo group. Conclusions: Despite overall low rates of alcohol consumption, there was a reduced risk of incident diabetes in those who reported modest daily alcohol intake and were assigned to metformin or lifestyle modification. Moderate daily alcohol intake is associated with lower insulin secretion-an effect that warrants further investigation. This trial was registered at clinicaltrials.gov as NCT00038727. Am J Clin Nutr 2009;90:595-601.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据